Healthcare Cuts & Politics: Reconciliation Risks | STAT News
Washington D.C. – As former President Donald Trump eyes a potential return to the White House, a key challenge looms: funding his ambitious policy agenda. A … Read more
pharmaceuticals
FDA Chief Makary Marks 1 Year Amidst Layoffs & RFK Jr. Criticism
WASHINGTON — Food and Drug Administration Commissioner Robert Califf, a physician himself, addressed agency staff Wednesday, striking a tone of gratitude and acknowledging a difficult first … Read more
Trump Tariffs: 100% Duty Planned on Imported Drugs & Ingredients
WASHINGTON — The Trump administration is preparing an executive order that would impose a 100% tariff on all prescription drugs and their key ingredients imported from … Read more
MAHA & Surgeon General Nomination Face Hurdles | D.C. Diagnosis
Washington D.C. Is witnessing a flurry of activity surrounding health savings accounts (HSAs) and Medicare Advantage Health Plans (MAHAs), with industry lobbying efforts intensifying even as … Read more
Wegovy Subscription Program: Lower Monthly Prices for Weight Loss Drug
Novo Nordisk, the Danish pharmaceutical giant, is taking a new step to address affordability and adherence for patients using its popular weight-loss drugs, Wegovy, and Ozempic. … Read more
Takeda Pharmaceuticals to Lay Off 250 in Cambridge, MA
Cambridge, MA – Takeda Pharmaceutical Company Limited will reduce its workforce in Cambridge, Massachusetts, by nearly 250 positions, the company announced Friday through a required state … Read more
Eli Lilly Signs $2.75B AI Drug Deal with Insilico Medicine
BEIJING — U.S. Pharmaceutical giant Eli Lilly has entered a $2.75 billion agreement with Hong Kong-based Insilico Medicine to accelerate the development and global distribution of … Read more
White House Drafts Drug Pricing Legislation, Shares with Pharma
WASHINGTON — The White House is actively engaging with pharmaceutical companies, sharing draft legislative text for a policy aimed at lowering prescription drug costs. This move, … Read more
AstraZeneca Stock Jumps on Positive COPD Drug Trial Results | $3-5B Sales Potential
Shares of AstraZeneca jumped nearly 5% in London trading Friday after the pharmaceutical giant announced positive results from late-stage clinical trials of tozorakimab, an experimental treatment … Read more
Adam Feuerstein on Tottenham Hotspur & Biotech Pain Points [STAT+ Exclusive]
The wait for definitive results from Allogene Therapeutics’ pivotal clinical trial of ALLO-719, an off-the-shelf CAR-T cell therapy for large B-cell lymphoma, is nearing an end. … Read more
